About Us

Read about our leadership, mission, goals & partnerships

TRAM Partnerships and Support

TRAM wants to announce support and interactions with the following individuals and organizations.


  • December 01, 2017: Protein Simple and Stanford TRAM and TASC begin an expanded collaboration to utilize single cell proteomic analysis for translational medical applications.  Previously, we have worked with Protein Simple using their PeggySue (Simple Western).  Now, the new technology, Milo, enables, quantitative protein analysis signals from individual cells.
  • July 18, 2018:  Tianjin Huanhu Hospital and Stanford TRAM discussed scientific interactions through a joint conference.  Dr. Zhang Peilan and Dr. Felsher presented scientific findings summarizing recent advances in translational medicine research in the managements of Cancer and Stroke through a joint symposium.
  • December 28, 2020:  Dr. George Tidmarsh, MD, PhD, Stanford MCHRI  with TRAM initiated support of a new graduate training program Translational Research.  The new mentored training program will include partnerships and interactions among multiple Stanford Departments, Institutes and Programs as well as interactions with Biotechnology Companies.  
  • August 15, 2021: Emulate, Stanford TRAM and TASC established a collaboration to utilize organ on chip experiments for the in situ analysis of disease pathogenesis, therapeutic response and molecular diagnostics.  Future studies will be involve multiple investigator research projects.
  • October 5, 2021:  The Asclepius Network and Stanford TRAM announce plans together to establish an advanced medical ecological system to support patients, doctors, institutions and scientists.   Asclepius has developed unique and innovative platforms that can greatly facilitate rapid medical translation. Their goal now will be to create together new smart medicines. There will be the opportunity for future medical research interactions through partnered research meetings and projects.  
  • December 7, 2021:  San Shen Biotechnology and Stanford TRAM plan to work together to build programs that support  translational medical research. Sanchen has developed novel approaches that will actualize the potential of novel therapeutics.  They plan to provide opportunities for new research and educational experiences for future leaders in medicine and science with a focus on applying integrated interdisciplinary approaches to solve complex problems.
  • March 15, 2023:  The Stanford Center for Translational Research and Applied Medicine is delighted  to form a strategic collaboration with MixTrust to jointly explore the application of biological information in Web3 DID certification.  MixTrust is a decentralized one-stop service platform that focuses on the Web3 DeFi field built on artificial intelligence technology that integrates modules such as digital identity, decentralized encrypted wallet, Web3 social, and AI financial services supporting mainstream public chains such as Ethereum, Arbitrum, and Aptos.

A gift to TRAM will further our mission to educate, inspire, and support scholars in translating their research discoveries into diagnostics and therapeutics to improve human health

The Stanford TRAM program was established with the goal of enabling both MD clinicians and PhD trained scientists to engage in team science translational clinical research involving human participants by providing core resources, research mentorship and training, pilot grants, a translational research seminar series and an annual translational medicine symposium. TRAM has as its overall goal to train students, residents, and fellows in performing research, to provide patients with state of the art clinical care, and to facilitate basic, clinical and translational medical research bringing together clinicians and researchers in new translational projects. Now entering its 11th year, TRAM has provided pilot funding for over 200 research projects that have involved over 500 students, fellows and faculty; supported over 150 seminars, mini-symposia and career perspectives and organized 10 annual research symposia.  TRAM also supported “personal perspectives” lectures from international leaders in medicine, organized an annual Symposium and Retreat, and built the first Translational Applications Service Center (TASC) that provides direct supervised training and support for processing and analyzing clinical human specimens, has unique proteomic technology, facilities for isolation or cells, RNA, DNA and protein and maintenance of human materials in vitro.

If you would like to make a donation to TRAM, please contact:

Renée LeBlanc
Medical Center Development
3172 Porter Drive, Suite 210
Palo Alto, CA 94304
Phone: (650)725-9689
Email: renee.leblanc@stanford.edu